山东大学教师主页窦蕾 Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China Home

Home > Scientific Research > Paper Publications

Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China

Release Time:2024-05-08 Hits:

Institution:卫生管理与政策研究中心
Journal:FRONT PHARMACOL
First Author:刘世贤
Document Code:1647786800804712450
Volume:14
Number of Words:15
Translation or Not:No
Date of Publication:2023-03

Prev One:Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease

Next One:Responsiveness and minimal clinically important difference of EQ-5D-5L in patients with coronary heart disease after percutaneous coronary intervention: A longitudinal study

Home

Scientific Research

Teaching Research

Awards and Honours

Enrollment Information

Student Information

My Album

Blog

Personal Information

Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China